AgiosRecent Data Breaches and Security Report

https://agios.com  ᛫  Biotech & Pharmaceuticals
Last updated October 26, 2018

Company Details

Company Overview

Agios Pharmaceuticals Inc. is a public American pharmaceutical company focused on developing small-molecule anti-cancer therapeutics targeting cancer cell metabolism via the growth factor pathway. Among the proteins under investigation by the company are IDH1 and IDH2. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.

Valuation

Employees

CEO

David Schenkein

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Agios

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's CSTAR Score ranges from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Agios

Get full security report ›

See UpGuard In Action

Book a call with one of our specialists and we'll arrange a time for a demo.